{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:53:00Z","timestamp":1790481180118,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP19\/00098"],"award-info":[{"award-number":["CP19\/00098"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["INT21\/00078"],"award-info":[{"award-number":["INT21\/00078"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00505"],"award-info":[{"award-number":["PI20\/00505"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.arr.2022.101696","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:05:48Z","timestamp":1657803948000},"page":"101696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk"],"prefix":"10.1016","volume":"80","author":[{"given":"Mohammad Shafi","family":"Kuchay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Mart\u00ednez-Montoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ramos-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2022.101696_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clnesp.2022.01.027","article-title":"Screening, diagnosis and monitoring of sarcopenia: when to use which tool","volume":"48","author":"Ackermans","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14218\/JCTH.2020.00065","article-title":"Skeletal muscle dysfunction in the development and progression of nonalcoholic fatty liver disease","volume":"8","author":"Altajar","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib4","doi-asserted-by":"crossref","first-page":"15938","DOI":"10.1038\/s41598-021-95581-8","article-title":"Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease","volume":"11","author":"Arai","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cmet.2020.08.004","article-title":"Alpha-ketoglutarate, an endogenous metabolite, extends lifespan and compresses morbidity in aging mice","volume":"32","author":"Asadi Shahmirzadi","year":"2020","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.arr.2022.101696_bib6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrendo.2013.64","article-title":"The GH\/IGF-1 axis in obesity: pathophysiology and therapeutic considerations","volume":"9","author":"Berryman","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7382","key":"10.1016\/j.arr.2022.101696_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostrom","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12072-019-09964-1","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Cai","year":"2020","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.arr.2022.101696_bib12","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/ggi.13030","article-title":"Circulating irisin levels as a predictive biomarker for sarcopenia: a cross-sectional community-based study","volume":"17","author":"Chang","year":"2017","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.arr.2022.101696_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","article-title":"Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease","volume":"299","author":"Chen","year":"2020","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib14","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jcsm.12754","article-title":"Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Chun","year":"2021","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib15","first-page":"1","article-title":"Understanding sarcopenia as a geriatric syndrome","volume":"13","author":"Cruz-Jentoft","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/dom.14206","article-title":"Mechanisms underlying the metabolic actions of testosterone in humans: a narrative review","volume":"23","author":"Dandona","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","article-title":"Sarcopenia from mechanism to diagnosis and treatment in liver disease","volume":"65","author":"Dasarathy","year":"2016","journal-title":"J. Hepatol."},{"issue":"24","key":"10.1016\/j.arr.2022.101696_bib19","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1113\/JP272796","article-title":"Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress","volume":"594","author":"Davuluri","year":"2016","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib20","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.30890","article-title":"Ammonia scavenging prevents progression of fibrosis in experimental nonalcoholic fatty liver disease","volume":"71","author":"De Chiara","year":"2020","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.arr.2022.101696_bib21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.dld.2019.03.002","article-title":"Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation","volume":"51","author":"Delogu","year":"2019","journal-title":"Dig. Liver Dis."},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.arr.2022.101696_bib24","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/liv.14205","article-title":"Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion","volume":"39","author":"Eriksen","year":"2019","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00223-016-0220-9","article-title":"The future prevalence of sarcopenia in Europe: a claim for public health action","volume":"100","author":"Ethgen","year":"2017","journal-title":"Calcif. Tissue Int"},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/clinem\/dgab884","article-title":"Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis","volume":"107","author":"Feng","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib27","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1038\/s41598-022-06614-9","article-title":"Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation","volume":"12","author":"Gallego-Duran","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1213\/ANE.0b013e3181eac1c9","article-title":"Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting","volume":"111","author":"Garcia","year":"2010","journal-title":"Anesth. Analg."},{"issue":"7","key":"10.1016\/j.arr.2022.101696_bib29","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13153","article-title":"Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis","volume":"5","author":"Giusto","year":"2017","journal-title":"Physiol. Rep."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib30","article-title":"Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease","volume":"2","author":"Golabi","year":"2020","journal-title":"JHEP Rep."},{"key":"10.1016\/j.arr.2022.101696_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.688526","article-title":"Sarcopenia: what is the origin of this aging-induced disorder?","volume":"12","author":"Gustafsson","year":"2021","journal-title":"Front Genet."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.14309\/ajg.0000000000000572","article-title":"Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk","volume":"115","author":"Han","year":"2020","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib34","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/hep.26716","article-title":"Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study","volume":"59","author":"Hong","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.arr.2022.101696_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/met.2021.0011","article-title":"Relationship between protein intake and sarcopenia in the elderly with nonalcoholic fatty liver disease based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey","volume":"19","author":"Hong","year":"2021","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib36","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2012-3290","article-title":"Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease","volume":"98","author":"Hribal","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/liv.14719","article-title":"Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease","volume":"41","author":"Hsieh","year":"2021","journal-title":"Liver Int."},{"issue":"12","key":"10.1016\/j.arr.2022.101696_bib38","doi-asserted-by":"crossref","first-page":"M772","DOI":"10.1093\/gerona\/57.12.M772","article-title":"Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women","volume":"57","author":"Iannuzzi-Sucich","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"10","key":"10.1016\/j.arr.2022.101696_bib39","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00125-013-2995-9","article-title":"Insulin-mediated suppression of lipolysis in adipose tissue and skeletal muscle of obese type 2 diabetic men and men with normal glucose tolerance","volume":"56","author":"Jocken","year":"2013","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nrendo.2013.67","article-title":"The GH\/IGF-1 axis in ageing and longevity","volume":"9","author":"Junnila","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib41","article-title":"Low skeletal muscle mass is a risk factor for subclinical atherosclerosis in patients with nonalcoholic fatty liver disease","volume":"11","author":"Kang","year":"2021","journal-title":"Diagn. (Basel)"},{"issue":"9","key":"10.1016\/j.arr.2022.101696_bib42","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/jgh.14607","article-title":"Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"34","author":"Kang","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.arr.2022.101696_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111267","article-title":"Estradiol deficiency and skeletal muscle apoptosis: possible contribution of microRNAs","volume":"147","author":"Karvinen","year":"2021","journal-title":"Exp. Gerontol."},{"issue":"13","key":"10.1016\/j.arr.2022.101696_bib44","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.18632\/aging.102068","article-title":"Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study","volume":"11","author":"Kim","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arr.2022.101696_bib45","doi-asserted-by":"crossref","unstructured":"Kim D., Wijarnpreecha K., Sandhu K.K., Cholankeril G., Ahmed A. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021;41(8):1832\u20131840.","DOI":"10.1111\/liv.14852"},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib46","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/hep.30049","article-title":"Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a 7-year longitudinal study","volume":"68","author":"Kim","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","article-title":"Sarcopenia and fatty liver disease","volume":"13","author":"Kim","year":"2019","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.arr.2022.101696_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-230X-12-69","article-title":"A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease","volume":"64","author":"Klair","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1478-3231.2011.02637.x","article-title":"Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients","volume":"32","author":"Koehler","year":"2012","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib51","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib53","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.dsx.2020.11.015","article-title":"Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib54","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","article-title":"Pathophysiological mechanisms underlying MAFLD","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"issue":"11","key":"10.1016\/j.arr.2022.101696_bib55","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1111\/jgh.15595","article-title":"Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease","volume":"36","author":"Kuchay","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib56","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.29107","article-title":"Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis","volume":"65","author":"Kumar","year":"2017","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.arr.2022.101696_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154089","article-title":"Metabolic reprogramming during hyperammonemia targets mitochondrial function and postmitotic senescence","volume":"6","author":"Kumar","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41419-020-03353-5","article-title":"Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFalpha","volume":"12","author":"Kurosawa","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib59","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.arr.2022.101696_bib60","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"50","key":"10.1016\/j.arr.2022.101696_bib61","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.02.051","article-title":"Sarcopenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Lee","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib63","doi-asserted-by":"crossref","first-page":"260","DOI":"10.21037\/hbsn.2018.12.10","article-title":"Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association","volume":"8","author":"Li","year":"2019","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib64","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jcsm.12784","article-title":"Understanding the gut microbiota and sarcopenia: a systematic review","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.arr.2022.101696_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112376","article-title":"Myostatin-1 inhibits cell proliferation by inhibiting the mTOR signal pathway and MRFs, and activating the ubiquitin-proteasomal system in skeletal muscle cells of Japanese flounder paralichthys olivaceus","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib66","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010008","article-title":"Sarcopenia, diet, physical activity and obesity in european middle-aged and older adults: the lifeage study","volume":"13","author":"Marcos-Pardo","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13367","article-title":"Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery","volume":"23","author":"Martinez-Montoro","year":"2022","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib69","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/ijms11041509","article-title":"Oxidative stress, molecular inflammation and sarcopenia","volume":"11","author":"Meng","year":"2010","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib70","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/j.2040-4603.2020.tb00136.x","article-title":"Role of skeletal muscle in insulin resistance and glucose uptake","volume":"10","author":"Merz","year":"2020","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.maturitas.2011.01.014","article-title":"Menopause and sarcopenia: a potential role for sex hormones","volume":"68","author":"Messier","year":"2011","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib72","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jcsm.12719","article-title":"Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey","volume":"12","author":"Moon","year":"2021","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","article-title":"Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000861","article-title":"Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease","volume":"9","author":"Naimimohasses","year":"2022","journal-title":"BMJ Open Gastroenterol."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcsm.12212","article-title":"Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib76","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/hep.26465","article-title":"Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"issue":"26","key":"10.1016\/j.arr.2022.101696_bib77","article-title":"Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: a cross-sectional study","volume":"100","author":"Oguz","year":"2021","journal-title":"Med. (Baltim.)"},{"issue":"10","key":"10.1016\/j.arr.2022.101696_bib78","doi-asserted-by":"crossref","first-page":"E1967","DOI":"10.1210\/jc.2014-1271","article-title":"Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer","volume":"99","author":"Padhi","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cen.14344","article-title":"Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease","volume":"94","author":"Pan","year":"2021","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1 Pt 1","key":"10.1016\/j.arr.2022.101696_bib80","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib82","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1096\/fj.04-2870fje","article-title":"Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction","volume":"19","author":"Phillips","year":"2005","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.arr.2022.101696_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166048","article-title":"Pro-inflammatory cytokines but not endotoxin-related parameters associate with disease severity in patients with NAFLD","volume":"11","author":"du Plessis","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145811","article-title":"Fatty liver index associates with relative sarcopenia and GH\/ IGF- 1 status in obese subjects","volume":"11","author":"Poggiogalle","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib85","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/liv.14876","article-title":"Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia","volume":"41","author":"Ponziani","year":"2021","journal-title":"Liver Int."},{"issue":"8","key":"10.1016\/j.arr.2022.101696_bib86","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00183.2012","article-title":"Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis","volume":"303","author":"Qiu","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"45","key":"10.1016\/j.arr.2022.101696_bib87","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-kappaB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib88","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.clnu.2017.08.016","article-title":"Does nutrition play a role in the prevention and management of sarcopenia?","volume":"37","author":"Robinson","year":"2018","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.arr.2022.101696_bib89","article-title":"Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study","author":"Roh","year":"2021","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib90","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000452499","article-title":"Testosterone deficiency and testosterone treatment in older men","volume":"63","author":"Saad","year":"2017","journal-title":"Gerontology"},{"issue":"4","key":"10.1016\/j.arr.2022.101696_bib91","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.00073.2004","article-title":"IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1","volume":"287","author":"Sacheck","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib92","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.arr.2022.101696_bib93","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib94","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cgh.2019.11.053","article-title":"Low testosterone is associated with nonalcoholic steatohepatitis and fibrosis severity in men","volume":"19","author":"Sarkar","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010805","article-title":"Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III","volume":"5","author":"Srikanthan","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib96","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","article-title":"Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease","volume":"106","author":"Stanley","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib97","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib98","doi-asserted-by":"crossref","first-page":"15647","DOI":"10.1038\/s41598-021-95108-1","article-title":"Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults","volume":"11","author":"Sun","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.arr.2022.101696_bib99","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1507\/endocrj.EJ12-0322","article-title":"Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver","volume":"59","author":"Takahashi","year":"2012","journal-title":"Endocr. J."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib101","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib102","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.2005.071118","article-title":"Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice","volume":"55","author":"Tomita","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12877-020-01910-3","article-title":"Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Geriatr."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib104","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12020-019-01982-1","article-title":"Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis","volume":"65","author":"Yao","year":"2019","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.arr.2022.101696_bib105","first-page":"343","article-title":"Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J. Nutr. Health Aging"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib106","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-018-0776-0","article-title":"Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.arr.2022.101696_bib107","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2013.04.030","article-title":"Irisin is inversely associated with intrahepatic triglyceride contents in obese adults","volume":"59","author":"Zhang","year":"2013","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.arr.2022.101696_bib108","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2337\/db13-1106","article-title":"Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling","volume":"63","author":"Zhang","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.arr.2022.101696_bib109","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1038\/s41598-020-73176-z","article-title":"Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.arr.2022.101696_bib110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cyto.2004.03.007","article-title":"Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism","volume":"26","author":"Zhu","year":"2004","journal-title":"Cytokine"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722001386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722001386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:04:29Z","timestamp":1761591869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163722001386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":110,"alternative-id":["S1568163722001386"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2022.101696","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2022.101696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101696"}}